Abstract:Copper complexes are considered as potential candidates for anticancer therapy and medical applications. In this paper, three new Cu(II) complexes, [Cu(IPY)2](ClO4)2·H2O (CuI1), [Cu(IPY)(L-Phe)H2O]ClO4·0.5H2O (CuI2) and [Cu(IPY)(L-Val)H2O]ClO4 (CuI3) (where IPY = 2-(1H-imidazol-2-yl)pyridine, L-Phe = L-phenylalanine, L-Val = L-valine), with good amphipathic properties were synthesized and characterized. The single crystal X-ray diffraction results revealed that CuI1 was four-coordinated, while CuI2 and CuI3 both adopted a five-coordinated tetragonal pyramidal configuration. Multi-spectral methods, viscosity experiment and molecular docking technique showed that three complexes interacted with DNA through insertion. The results of the gel electrophoresis experiments indicated that DNA was oxidatively cleaved by all the complexes in a concentration-dependent manner. Moreover, singlet oxygen (1O2), hydrogen peroxide (H2O2) and superoxide anion radicals (·O2−) were associated with oxidative cleavage of DNA. All the complexes also had good binding affinity with human serum albumin (HSA). The MB degradation assay revealed that all complexes could react with H2O2 to form ·OH through Fenton-like processes. The complexes displayed good antiproliferative activity against the tested human cancer cells in vitro, including cervical carcinoma cells (HeLa), liver cancer cells (HepG2 and BEL-7402) and gastric adenocarcinoma cells (SGC-7901), but showed lower toxicity to normal liver cells (LO2). The anticancer mechanism research revealed that CuI1, CuI2 and CuI3 arrested the cell cycle at S phase, elevated intracellular reactive oxygen species (ROS) levels and induced loss of mitochondrial membrane potential (MMP). The results indicated that these Cu(II) complexes could induce DNA damage and ROS-mediated mitochondrial dysfunction, leading to cancer cell apoptosis. Our work provided a theoretical basis for the design of new low-toxic and highly efficient anticancer Cu(II) complexes by incorporating biological metabolites and aromatic heterocycle ligands.

Synthesis, Crystal Structure, DNA/bovine Serum Albumin Binding and Antitumor Activity of Two Transition Metal Complexes with 4‐acylpyrazolone Derivative

Synthesis, interaction with DNA and bovine serum albumin of the transition metal complexes of demethylcantharate and 2-aminobenzothiazole.

Synthesis, Crystal Structure and Biological Activity of Two Mn Complexes with 4-Acyl Pyrazolone Derivatives

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Two Cu(II) Complexes Containing 2,4-Diamino-6-(2-pyridyl)-1,3,5-triazine and Amino Acids: Synthesis, Crystal Structures, DNA/HSA Binding, Molecular Docking, and in Vitro Cytotoxicity Studies

Synthesis, Characterization, DNA Binding and Cleavage, BSA Interaction and Anticancer Activity of Dinuclear Zinc Complexes.

Synthesis, crystal structures, anticancer activities and molecular docking studies of novel thiazolidinone Cu( ii ) and Fe( iii ) complexes targeting lysosomes: special emphasis on their binding to DNA/BSA

Synthesis, Characterization, and Biological Activities of Two Cu(II) and Zn(II) Complexes with One Polyquinoline Ligand.

Synthesis, Characterization, DNA/HSA Interactions and in Vitro Cytotoxic Activities of Two Novel Water-Soluble Copper(ii) Complexes with 1,3,5-Triazine Derivative Ligand and Amino Acids.

Three Structurally Related Copper Complexes with Two Isomers: DNA/BSA Binding Ability, DNA Cleavage Activity and Excellent Cytotoxicity

Two Water-Soluble Copper(ii) Complexes: Synthesis, Characterization, DNA Cleavage, Protein Binding Activities and in Vitro Anticancer Activity Studies.

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Synthesis, characterization, and antitumor activities of two copper(II) complexes with pyrazole derivatives

Three water-soluble acylhydrazone tetranuclear transition metal complexes: Crystal structures, DNA/BSA interactions and cytotoxicity studies

Synthesis, Crystal Structures and DNA/human Serum Albumin Binding of Ternary Cu(II) Complexes Containing Amino Acids and 6‐(Pyrazin‐2‐yl)‐1,3,5‐triazine‐2,4‐diamino

Synthesis and Crystal Structure of Some Transition Metal Complexes with A Novel Bis-Schiff Base Ligand and Their Antitumor Activities

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Synthesis, Characterization, Interaction with DNA and Cytotoxicity in Vitro of Novel Pyridine Complexes with Zn(II)

Synthesis, crystal structure, DNA binding properties and antioxidant activities of transition metal complexes with 3-carbaldehyde-chromone semicarbazone

Crystal Structures, DNA-binding and Cytotoxic Activities Studies of Cu(II) Complexes with 2-Oxo-quinoline-3-carbaldehyde Schiff-bases

Synthesis, Crystal Structure, Dna Binding, Antibacterial, and Cytotoxic Activities of Two Chiral Copper(Ii) Complexes